Our purpose is to save lives, alleviate suffering and improve the economic efficiency of the leading acute | intensive care hospitals in the world. We aim to be a leading provider of solutions and knowledge to improve health outcomes in these hospitals.

In pursuit of this purpose we invite you to join us here at The Medicines Company. Our success in the acute | intensive care setting truly depends on our collective contributions to a combined intelligence, rigor, energy and skill of the brightest and best in the world.

The Medicines Company aims to lead in acute | intensive care medicine worldwide. There is no higher priority for us than improving health outcomes for patients in ever more cost effective ways.

Today, delivering authentic healthcare innovation worldwide is more challenging and complex than ever. It demands a sharp focus on what customers need. It requires the development and delivery of data, knowledge and products that make a difference.

Employees of our Company are committed to a culture of honesty, integrity and accountability and we apply these principles in our everyday business activities. We provide products and knowledge that directly impact the survival and well-being of people in hospitals who are critically ill with conditions such as heart attacks and acute, severe hypertension. In view of this impact, we put patient well-being first in our decisions. That means that we have to put the interests of other stakeholders second – including customers, shareholders and employees. Fortunately, as a practical matter, we don’t often face a concrete, synchronous choice between the well-being of patients and the interests of other stakeholders. But when we do, in all aspects of our business, the ancient aphorism ―primum non nocere‖ (first, do no harm) is operative.

There is no higher priority for us than improving health outcomes for patients in cost effective ways. When delivering authentic healthcare innovation, we maintain the highest standards of moral, ethical and professional conduct.